Chronic immune thrombocytopenic purpura in childhood

Seminars in Thrombosis and Hemostasis

Volumn 24, Issue 6, 1998, Pages 549-553

  Kühne, Thomas ^a   Imbach, Paul ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Autoantibodies; Child; Chronic; Immune thrombocytopenic purpura

Indexed keywords

DEXAMETHASONE; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; PREDNISONE; RHESUS D ANTIBODY;

AUTOIMMUNE DISEASE; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DISEASE CLASSIFICATION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SPLENECTOMY; THROMBOCYTE COUNT;

EID: 0032449584     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-996054     Document Type: Review

References (50)

1. 1. Imbach P, Barandun S, D'Appuzzo V, et al. High-dose intravenous gamma globulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981;1:1228-1231
2. 2. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for The American Society of Hematology. Blood 1996;88:3-40
3. 3. McMillan R, Longmire RL, Yelenosky R, Donnell RL, Armstrong S. Quantitation of platelet-binding IgG produced in vitro by spleens from patients with idiopathic thrombocytopenic purpura. N Engl J Med 1974;291:812-817
4. 4. McMillan R, Yelenosky RJ, Longmire RL. Antiplatelet antibody production by the spleen and bone marrow in immune thrombocytopenic purpura. In: Battisto JR, Streinlein JW, eds. Immunoaspects of the Spleen. Amsterdam: North Holland Biomedical Press; 1976:227-237
5. 5. McMillan R, Luiken GA, Vevy R, Yelenosky R, Longmire RL. Antibody against megakaryocytes in idiopathic thrombocytopenic purpura. JAMA 1978;239:2460-2462
6. 6. Heyns AP, Badenhorst PN, Lotter MG, et al. Platelet turnover and kinetics in immune thrombocytopenic purpura: Results with autologous 111-In-labeled and homologous 51-Cr-labeled platelets differ. Blood 1986;67:86-92
7. 7. Stoll D, Cines DB, Aster RH, Murphy S. Platelet kinetics in patients with idiopathic thrombocytopenic purpura and moderate thrombocytopenia. Blood 1985;65:584-588
8. 8. Aster RH, Keene WR. Sites of platelet destruction in idiopathic thrombocytopenic purpura. Br J Haematol 1969;16:61-73
9. 9. Branehog I, Kutti J, Weinfeld A. Platelet survival and production in idiopathic thrombocytopenic purpura (ITP). Br J Haematol 1974;27:127-143
10. 10. McMillan R, Tani P, Millard F, et al. Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood 1987;70:1040-1045
11. 11. Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): A new tool for the identification of platelet-reactive antibodies. Blood 1987;70:1722-1726
12. 12. McMillan R. Antigen-specific assays in immune thrombocytopenic purpura. Trans Med Rev 1990;4:136-143
13. 13. Kiefel V, Santoso S, Kaufmann E, Mueller-Eckhardt C. Autoantibodies against platelet glycoprotein Ib/IX: A frequent finding in autoimmune thrombocytopenic purpura. Br J Haematol 1991;79:256-262
14. 14 Imbach P, Tani P, Berchtold W, et al. Different forms of chronic ITP in children defined by antiplatelet autoantibodies. J Pediatr 1991;118:535-539
15. 15. Kurata Y, Curd JG, Tamerius JD, McMillan R. Platelet-associated complement in chronic ITP. Br J Haematol 1985;60: 723-733
16. 16. Clarkson SB, Bussel JB, Kimberly RP, et al. Treatment of refractory immune thrombocytopenic purpura with anti-Fc-receptor antibody. N EngI J Med 1986;314:1236-1239
17. 17. Tsubakio T, Tani P, Curd JG, McMillan R. Complement activation in vitro by antiplatelet antibodies in chronic immune thrombocytopenic purpura. Br J Haematol 1985;63:293-300
18. 18. Semple JW, Freedman J. Abnormal cellular immune mechanisms associated with autoimmune thrombocytopenia. Trans Med Rev 1995;4:327-338
19. 19. Imbach P. Immune thrombocytopenia in children: The immune character of destructive thrombocytopenia and the treatment of bleeding. Semin Thromb Hemost 1995;21:305-312
20. 20. Imbach P, Akatsuka J, Blanchette V, et al. Immunthrombocytopenic purpura as a model for pathogenesis and treatment of autoimmunity. Eur J Pediatr 1995;154(9 suppl 4):S60-S64
21. 21. Imbach PA, Kühne T, Hollander G. Immunologie aspects in the pathogenesis and treatment of immune thrombocytopenic purpura in children. Curr Opin Pediatr 1997;9:35-40
22. 22. Kaplan C, Morinet F, Cartron J. Virus-induced autoimmune thrombocytopenia and neutropenia. Semin Hematol 1992;29: 34-44
23. 23. Semple JW, Freedman J. Increased anti-platelet T-helper lymphocyte reactivity in patients with autoimmune thrombocytopenic purpura. Blood 1991;78:2619-2625
24. 24. Semple JW, Milev Y, Cosgrave D, et al. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: Relationship to platelet phenotype and antiplatelet T-cell reactivity. Blood 1996;87:4245-4254
25. 25. Crosby WH. Wet purpura, dry purpura. JAMA 1975;232:744-745
26. th ed. Berlin: Hirschwald; 1899
27. 27. Woerner SJ, Abildgaard CF, French BN. Intracranial hemorrhage in children with idiopathic thrombocytopenic purpura. Pediatrics 1981;67:453-460
28. 28. Blanchette VS, Turner C. Treatment of acute idiopathic thrombocytopenic purpura. J Pediatr 1985;108:326-327
29. 29. Lilleyman JS. Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Arch Dis Child 1994;61:251-253
30. 30. Lilleyman JS. Intracranial hemorrhage in chronic childhood ITP. Pediatr Hematol Oncol 1997;14:iii-v
31. 31. Lusher JM, Zuelzer WW. Idiopathic thrombocytopenic purpura in childhood. J Pediatr 1966;68:971-979
32. 32. Robb LG, Tiedeman K. Idiopathic thrombocytopenic purpura: Predictors of chronic disease. Arch Dis Child 1990;65: 502-506
33. 33. Blanchette VS, Kirby MA, Turner C. Role of intravenous immunoglobulin G in autoimmune hematologic disorders. Semin Hematol 1992;29:72-82
34. 34. Halperin DS, Doyle JJ. Is bone marrow examination justified in idiopathic thrombocytopenic purpura? Am J Dis Child 1988; 142:508-511
35. 35. Sekul EA, Cupler EJ, Dalakas MC. Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: Frequency and risk factors. Ann Intern Med 1994;121:259-262 s
36. 36. Kaltamis AC, Shankar S, Cohen AR. Neurologie complications of treatment of childhood acute immune thrombocytopenic purpura with intravenously administered immunoglobulin G. J Pediatr 1997;s130:281-283
37. 37. Lammi AT, Lovric VA. Idiopathic thrombocytopenic purpura: An epidemiologic study. J Pediatr 1973;83:31-36
38. 38. Robb LG, Tiedeman K. Idiopathic thrombocylopenic purpura: Predictors of chronic disease. Arch Dis Child 1990;65:502-506
39. 39. Yoshida K, Yamazaki Y, Mizuno R, et al. Laparoscopic splenectomy in children: Preliminary results and comparison with the open technique. Surg Endosc 1995;9:1279-1282
40. 40. Farah RA, Rogers ZR, Thompson WR, et al. Comparison of laparoscopic and open splenectomy in children with hematologic disorders. J Pediatr 1997;131:41-46
41. 41. Holdsworth RJ, Irving AD, Cuschieri A. Postspleneetomy sepsis and its mortality rate: Actual versus perceived risks. Br J Surg 1991;78:1031-1038
42. th ed. Philadelphia: WB Saunders; 1998:1585-1630
43. 43. Kühne T, Egli D, Imbach P. Epidemiology of childhood immune thrombocytopenic purpura (TTP) in a defined area in Europe and rationale and profile of an intercontinental childhood ITP registry. Blood 1997;90:85b. Abstract
44. 44. Aronis S, Platokouki H, Mitsika A, Haidas S, Constantopoulos A. Seventeen years of experience with chronic idiopathic thrombocytopenic purpura in childhood. Is therapy always better? Pediatr Hematol Oncol 1994;11:487-498
45. 45. von dem Borne AEGK, Vos JJE, Peels JG, Thomas LLM, van der Lelie H. High dose intravenous methylprednisolone or high dose intravenous gammaglobulin for autoimmune thrombocytopenia. BMJ 1988;296:249-250
46. 46. Imholz B, Imbach P, Baumgartner C, et al. Intravenous immunoglobulin (i.v. IgG) for previously treated acute or for chronic idiopathic thrombocytopenic purpura (ITP) in childhood: A prospective multicenter study. Blut 1988;56:63-68
47. 47. Warrier IA, Lusher JM. Intravenous gammaglobulin (Gamimune) for treatment of chronic idiopathic thrombocytopenic purpura (ITP): A two-year follow-up. Am J Hematol 1986;23:323-328
48. 48. Andersen JC. Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy. N Engl J Med 1994;330:1560-1564
49. 49. Kühne T, Freedman J, Semple JW, et al. Platelet and immune responses to oral cyclic dexamethasone therapy in childhood chronic immune thrombocytopenic purpura. J Pediatr 1997; 130:17-24
50. 50. Imbach P, Blanchette VS, Nugent D, Kühne T. Immune thrombocytopenic purpura: Immediate and long-term effects of intravenous immunoglobulin. In: Kazatchkine MD, Morell A, eds. Intravenous Immunoglobulin Research and Therapy. London: Parthenon Publishing; 1996:135-141 s